$VOR
Vor Biopharma Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
VOR chart
What traders are saying about $VOR
Latest postsVor Biopharma Inc. news
- Vor Biopharma Inc. Estimates – NASDAQ:VOR
TradingView ·
- Vor Biopharma (VOR) After TELIGAN Data Has An Undervalued Narrative Back In Focus
Simply Wall Street ·
- Vor Biopharma Inc. (VOR) stock price, news, quote and history
Yahoo Finance Australia ·
- Learn Why The Bull Case For Vor Biopharma Stock Could Change Following Phase 3 Kidney Trial Results
Simply Wall Street ·
- Vor Bio (VOR) Reports Positive Phase 3 Trial Results for Telitac
GuruFocus ·
- Vor Bio says its experimental drug slowed loss of kidney function in late-stage study
Reuters ·
- Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy
Yahoo Finance ·
- A kidney treatment was linked to 89% lower risk of a confirmed 30% kidney-function drop over two years.
Stock Titan ·
- Vor Biopharma (VOR) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $VOR
MarketBeat ·
- William Blair Initiates Vor Biopharma(VOR.US) With Buy Rating
Moomoo ·
- Vor Biopharma (VOR) Could Be 52% Undervalued As Phase 3 gMG Data Draw Focus
Yahoo Finance ·
- Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
Vor Biopharma Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$696.0M | -$116.9M | -$117.9M | -$92.1M |
| Diluted EPS | $-70.50 | $-34.03 | $-1.75 | $-2.33 |
| Total assets (year end) | $464.1M | $142.9M | $198.1M | $299.4M |
| Cash and equivalents (year end) | $396.5M | $81.9M | $31.4M | $57.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Vor Biopharma Inc.
- Ticker
- VOR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Fiscal year end
- December 31
- SEC CIK
- 1817229
Frequently asked questions
What exchange is Vor Biopharma Inc. listed on?
Vor Biopharma Inc. trades on the Nasdaq under the ticker symbol VOR.
What industry is Vor Biopharma Inc. in?
Vor Biopharma Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Vor Biopharma Inc. headquartered?
Vor Biopharma Inc.'s business address on file with the SEC is in Boston, MA.
When does Vor Biopharma Inc.'s fiscal year end?
Vor Biopharma Inc.'s fiscal year ends on December 31.